Background
==========

Stroke is the third leading cause of death and the major cause of severe disability and impairment in the industrialized world \[[@B1]\]. In Europe, about 250 strokes/100.000 inhabitants occur every year, with a rising trend \[[@B2]\]. Following a stroke, patients frequently suffer severe disability and marked limitations in activities of daily living. Postural instability is one of the major deficits following a stroke, with associated increased risk of fall; a consequence of this problem is reduced mobility, increased disability and even mortality \[[@B3]-[@B8]\]. Stroke subjects who retain the ability to stand show delayed and disrupted equilibrium reactions, exaggerated postural sway in both sagittal and frontal planes, reduced weight-bearing on the paretic limb and increased risk of falling \[[@B9]\]. The clinical and social impact of postural instability has produced a great deal of research in this field that allowed the development of several functional tests and laboratory methods (posturography) to explore the extent of balance dysfunction \[[@B10]\].

Both these functional test and posturographic techniques have been applied to specifically investigate balance deficits in stroke patients \[[@B11],[@B12]\]. Quantitative posturography utilizes force plates to monitor the trajectory of the centre of pressure (CoP). The CoP trajectory reflects the body sway during standing and the ability of the nervous and musculoskeletal systems to integrate information from multiple sensory systems, including the visual, the somatosensory, and the vestibular system to maintain balance \[[@B13],[@B14]\]. Alterations of the postural control system are reflected in changes of CoP characteristics and parameters \[[@B13],[@B14]\], which is therefore a key variable for monitoring the postural control system \[[@B13]-[@B16]\]. Although instrumented posturography has demonstrated its validity in monitoring balance, the use of force plates in the clinical practice is not yet common and simple test batteries and questionnaires to test balance and mobility are often employed as useful alternatives \[[@B7],[@B11],[@B17]\]. Some of these tests and scales, which are described in detail in the Methods section, include the Fugl-Meyer scale (FM) \[[@B18]\]; the lower Motricity Index (lo-MI) \[[@B19]\]; the Trunk Control Test (TCT) \[[@B20]\]; the Functional Independence Measure (FIM) \[[@B21]-[@B24]\]; the Tinetti Balance scale (TB) \[[@B7]\]; the Berg Balance Test (BBT) \[[@B24]\]; and the Time up and go Test (TUG) \[[@B17]\]. Some of these tests have proved to be a valid and reliable indicator for balance ability \[[@B12]\]. For instance, in a study by Bogle et al. (1996), falls in stroke patients were associated with poor performance in the Berg Balance Scale \[[@B25]\]. However, the individual clinical functional tests do not reflect the complexity and multidimensional nature of balance \[[@B26]\].

While both functional tests and instrumented measures are used to monitor balance function in stroke subjects, with the clinical settings relying mostly on the former, their relationship and their usefulness as means for obtaining reliable feedback on the patient balance impairments and for evaluating the effects of a rehabilitative treatment has not been investigated yet. Therefore, the aim of this study is to assess postural stability using both computerised posturography and functional balance tests in chronic post-stroke patients and to investigate their relation.

Methods
=======

Participants
------------

20 subjects participated in the study, 10 control subjects (CS) and 10 hemiplegic post-stroke subjects (SS).

SS patients were recruited from the outpatient clinic of the Rehabilitation Department of the University of Padova (Italy). All patients were diagnosed with chronic post-stroke hemiplegia/hemiparesis (\> 1 year from onset) and were able to walk independently or with supervision (Functional Ambulation Classification scores ≥3) \[[@B27]\]. Exclusion criteria for SS were: concomitant cardiovascular disease; other neurological or psychiatric diseases; severe visual or auditory impairments (reduced visual acuity was accepted if adequately corrected). Patients with multiple cerebrovascular lesions or with infratentorial lesion were not recruited. Patients were also excluded if their pharmacological therapy changed during the trial or in the previous month; or if they attended a rehabilitation treatment during the study or in the 3 months before the study.

The CS consisted of healthy subjects enrolled among hospital personnel. The study was approved by the ethics committee of the Hospital of Padova (Italy). An informed consent form was obtained from all participants.

SS and CS subject groups were matched for age and BMI. Mean age was 69.4 ± 8.21 years for SS and 61.60 ± 8.57 years for CS (p = 0.058); mean BMI was 25.16 ± 2.48 kg/m^2^ for SS and 27.30 ± 2.24 kg/m^2^ for CS (p = 0.066). Body mass and height did not differ: mean body mass for SS and CS was 80.00 ± 12.26 kg and 80.30 ± 8.12 kg, respectively (p = 0.950); mean height was 177.56 ± 9.08 cm and 172.30 ± 5.43 cm, respectively (p = 0.140). The time since stroke for the SS group was on average 7.5 ± 8.9 years.

Clinical and instrumental evaluation
------------------------------------

Instrumental evaluation consisted in the Romberg test, which was performed on all subjects with 1 Bertec force plate (FP4060-10, 960 Hz). Subjects were asked to stand on the force plate, with their feet placed so as to maintain the heels together and a 30 degrees angle between the right and left toes, and to relax the arms along the body \[[@B28]\]. To ensure similar angles between the feet throughout the test, a guide made of heavy cardboard was placed on the force plate, and the subjects lined their feet up along both arms of the foot-guide. Once the subjects assumed the correct posture, they were asked to maintain the upright standing position for 60 s with their eyes open (EO) while looking at a circular target placed at a distance of 4 m in front of them and then to maintain the same position for 60 s with their eyes closed (EC) \[[@B29]\]. The CoP trajectory was acquired during the Romberg test. The signal underwent a post-acquisition filtering and downsampling technique, thus reducing the frequency to 100 samples/s (the first 20 s of the signal were not analyzed) \[[@B13],[@B14],[@B18],[@B29]\] From the CoP signals the following posturographic parameters were computed \[[@B13],[@B14],[@B18],[@B29]\]: the sway area, which is a measure of the area included in CoP displacement per unit of time (mm^2^/s); the ellipse containing 95% of the CoP data point; the CoP path, calculated as the total length of the CoP path; the CoP path in both in the anterior-posterior (AP) and in the medio-lateral (ML) directions, which are approximated by the sum of the distances between consecutive points in the AP and ML directions; and the CoP velocity (CoPv), as well the CoP velocity in both the AP and in the ML directions. All data analysis was performed using the Matlab software.

The following clinical tests were administered exclusively to the SS subjects to quantify their motor and functional impairment and their degree of disability: Fugl-Meyer scale for lower limbs (FM); Motricity Index for lower limbs (lo-MI); Trunk Control Test (TCT); and Functional Independence Measure (FIM).

The FM scale is a multi-item Likert-type scale developed as an evaluative measure of recovery from hemiplegic stroke. We used the subscale for motor domain of the lower limbs that includes items quantifying movement, coordination, and reflex action about the hip, knee, and ankle; with motor score ranging from 0 (hemiplegia) to a maximum of 34 points (normal motor performance) \[[@B19]\]. lo-MI is an ordinal weighted scale used to assess the severity of motor impairment of the lower limb after a stroke. Essentially, it tests 6 limb movements while the patient is sitting on a chair or on the edge of the bed \[[@B20]\]. The Trunk Control Test evaluates three movements and one posture (balance in sitting position). The total score ranges from 0 to 100 points, a higher score indicating a better trunk performance \[[@B21]\]. FIM is a scale that measures the severity of disability and the outcomes of adult inpatient medical rehabilitation. It describes the level of independence on 18 items covering the domains of self-care, sphincter management, transfers, locomotion, communication, and social cognition. Each item is rated 1--7, with the higher rating indicating more independent performance. Total scores range from 18 to 126. The 13-item motor domain (range, 13--91) and the five-item cognitive domain (range, 5--35) are commonly scored separately \[[@B22]-[@B24],[@B30]\].

The following clinical balance scales were administered to SS subjects to specifically evaluate their balance impairment: Tinetti Balance assessment tool (TB); Berg Balance Test (BBT); Time up and go Test (TUG).

The TB assessment tool is a simple, easily administered test that measures a patient's gait and balance. Scoring is performed on a three point ordinal scale, ranging from 0 to 2. The individual scores are then combined to form three measures: an overall gait assessment score, an overall balance assessment score, and a gait and balance score \[[@B7]\]. In our work, we only considered the balance assessment score, with a maximum of 16 points. The BBT was developed to measure balance impairment among elderly people by assessing the performance of specific functional tasks. It's a 14-item scale with a five-point scale, ranging from 0 to 4: ′0′ indicates the lowest level of function abilities and ′4′ the highest level of function abilities, with a total score of 56 \[[@B30]\]. The TUG test is a simple and quick functional mobility test that measures the time taken by an individual resting on a chair to stand in an upright position and to sit down again \[[@B17]\].

Statistical analysis
--------------------

Comparison between SS and CS subjects was performed by means of the Student t-test or Mann--Whitney U-test (SPSS v 13 Software), when appropriate based on the Levene's Test for Equality of means. The Pearson Correlation coefficient was computed between instrumental and clinical balance parameters (SPSS v 13 Software). The threshold for statistical significance was set to p \< 0.05.

Results
=======

Clinical measures are reported in Table [1](#T1){ref-type="table"} for SS subjects. Note that one of the subjects abandoned the study because his pharmacological therapy changed during the trial. Mean values for the balance scale scores were 12.5 ± 3.6 for TB, 42.9 ± 13.1 for BBT, 24 s and 75 cent ± 25 s and 70 cent for TUG, respectively.

###### 

Clinical measurements for post-stroke subjects

              **Subject \#**              **1**    **2**    **3**   **4**   **5**   **6**   **7**   **8**   **9**   **10**
  -------------------------------------- ------- --------- ------- ------- ------- ------- ------- ------- ------- --------
           **MOTOR IMPAIRMENT**                                                                                    
           **Fugl-Meyer (leg)**            28       25       31      24      28      24      27      26      22       20
        **Motricity Index (leg)**          99       64       99      83      36      83      91      91      59       72
          **Trunk Control Test**           41       37       100     74      99      61      100     87      87       61
   **Functional Indipendence Measure**     125      50       126     122     126     115     123     117     83      101
            **BALANCE SCORES**                                                                                     
   **Time up and go (minutes/seconds)**   16′05   1′34′37   8′33    25′02   10′94    29′    9′09    10′36   29′09    8′45
          **Berg Balance Test**            48       14       56      46      56      36      52      48      30       43
           **Tinetti Balance**            14/16    6/16     16/16   11/16   16/16   12/16   16/16   16/16   9/16     9/16

Values for the clinical tests performed for post-stroke subjects. Note that only 9 subjects are reported because the pharmacological therapy of one subject changed during the trial.

The CoP trajectory was computed from the force data acquired during the Romberg test in the EO and EC conditions. Results of all posturographic parameters are reported in Table [2](#T2){ref-type="table"} (EO) and Table [3](#T3){ref-type="table"} (EC) and in Figure [1](#F1){ref-type="fig"} for SS and CS subjects, together with the p-value for significance. Statistically significant differences were found between SS and CS in all CoP parameters in EO condition (p \< 0.05). In EC condition, significant differences were observed in the CoP path and in the CoP velocity and both the CoP path and velocity in the AP direction.

###### 

Centre of pressure (CoP) parameters: Romberg test in eyes open (EO) condition

  **CoP Parameters**                    **SS**           **CS**       **P-values**
  --------------------------------- --------------- ---------------- --------------
  **Ellipse (mm**^**2**^**)**        647.9 ± 449.6   312.26 ± 168.5     0.042\*
  **Sway Area (mm**^**2**^**/s)**     43.6 ± 31.2      15.4 ± 7.4       0.005\*
  **Path (mm)**                      665.1 ± 295.9    352.9 ± 82.6      0.005\*
  **Path ML (mm)**                   384.9 ± 266.0    186.4 ± 43.4      0.032\*
  **Path AP (mm)**                    444.4 ± 214     259.1 ± 62.9      0.018\*
  **CoPv (mm/s)**                     17.80 ± 9.1      8.82 ± 2.1       0.007\*
  **CoPv ML (mm/s)**                  10.1 ± 6.8       4.7 ± 1.1        0.022\*
  **CoPv AP (mm/s)**                  12.1 ± 7.3       6.5 ± 1.6        0.031\*

Parameters computed from the CoP trajectory acquired during the Romberg Test in the EO condition for post-stroke (SS, second column) and control subjects (CS, third column). All parameters were significantly different between SS and CS, as indicated by the p-values on the right-hand side column (the asterisks mark the values exceeding the threshold for significance, p \< 0.05). Values are reported as mean ± standard deviation.

###### 

Centre of pressure (CoP) parameters: Romberg test in eyes closed (EC) condition

  **CoP Parameters**                 **Stroke subjects**   **Control subjects**   **P-values**
  --------------------------------- --------------------- ---------------------- --------------
  **Ellipse (mm**^**2**^**)**           425.5 ± 180.5         309.3 ± 169.2          0.195
  **Sway Area (mm**^**2**^**/s)**        38.3 ± 31.6            17.9 ± 8.4           0.067
  **Path (mm)**                         610.8 ± 192.2         412.7 ± 122.6         0.020\*
  **Path ML (mm)**                      275.5 ± 86.1          215.80 ± 76.4          0.153
  **Path AP (mm)**                      494.4 ± 170.4          305.1 ± 85.5         0.008\*
  **CoPv (mm/s)**                        18.2 ± 10.0            10.3 ± 3.1          0.033\*
  **CoPv ML (mm/s)**                      8.4 ± 5.2             5.4 ± 1.9            0.117
  **CoPv AP (mm/s)**                     14.6 ± 7.6             7.6 ± 2.1           0.015\*

Parameters computed from the CoP trajectory acquired during the Romberg Test in the EC condition for post-stroke (SS, second column) and control subjects (CS, third column). CoP path and velocity (CoPv), and the component in the antero-posterior direction were significantly different between SS and CS, as indicated by the p-values on the right-hand side column (the asterisks mark the values exceeding the threshold for significance, p \< 0.05). Values are reported as mean ± standard deviation.

![**Boxplots of the posturographic parameters.** Stroke subjects (SS) always on the right, Control Subjects (CS) always on the left. From left to right vertical axes represent: the ellipse 95% (Ellipse 95%), the sway area (Sway Area), the total path (Path), the path in medio-lateral direction (Path ML), the path in anterior-posterior direction (Path AP), the total mean velocity (Mean Velocity), the mean velocity in in medio-lateral direction (Mean Velocity ML), and the mean velocity in anterior-posterior direction (Mean Velocity AP). Both eyes open (EO) and eyes closed (EC) condition have been reported.](1743-0003-10-95-1){#F1}

Regarding the correlation analysis results, it should be noticed that TB scores did not correlate with any instrumental measurements. Similarly, no correlation was observed among clinical scales and ellipse values, CoP path values, and CoP path values in the ML direction. In contrast, BBT was correlated with CoP path and CoPv in the AP direction in EO condition; with all CoPv-based parameters in EC condition. Similarly, moderate to high correlation was found, both in the EO and EC conditions, among TUG scores and sway area, CoP path in the AP direction and all CoPv-based parameters; with the only exceptions of CoP path in the AP direction with EC and CoPv in the ML direction with EO. See Table [4](#T4){ref-type="table"} for details.

###### 

Correlations between clinical balance scales and laboratory measures

                                      **EO**      **EC**                                              
  ------------------------------- -------------- --------- --------- ------------ --------- --------- ---------
    **Ellipse (cm**^**2**^**)**    **R**^**2**^    0.08      -0.20       0.18       0.25      -0.24     0.47
            **p-value**               0.580        0.400     0.320      0.558       0.560     0.240   
   **Sway Area (cm**^**2**^**)**   **R**^**2**^    -0.15     -0.59       0.76       -0.25     -0.69     0.89
            **p-value**               0.470        0.090    0.011\*     0.545       0.06     0.004\*  
           **Path (cm)**           **R**^**2**^    -0.15     -0.25       0.33       -0.37     -0.49     0.50
            **p-value**               0.470        0.330     0.110      0.361       0.280     0.210   
         **Path ML (cm)**          **R**^**2**^    -0.17     0.15       -0.02       -0.42     -0.64     0.69
            **p-value**               0.450        0.380     0.670      0.299       0.080     0.060   
         **Path AP (cm)**          **R**^**2**^    -0.06     -0.74       0.86       -0.33     -0.33     0.37
            **p-value**               0.600       0.010\*   0.001\*     0.417       0.430     0.360   
          **CoPv (cm/s)**          **R**^**2**^    -0.18     -0.43       0.67       -0.32     -0.75     0.89
            **p-value**               0.430        0.146    0.034\*     0.445      0.030\*   0.003\*  
        **CoPv ML (cm/s)**         **R**^**2**^    -0.19     0.09        0.09       -0.31     -0.79     0.93
            **p-value**               0.410        0.550     0.500      0.454      0.018\*   0.001\*  
        **CoPv AP (cm/s)**         **R**^**2**^    -0.10     -0.78       0.92       -0.32     -0.71     0.86
                                   **p-value**     0.540    0.010\*   \< 0.001\*    0.430    0.040\*   0.010\*

R^2^-values and p-values for the correlation analysis between clinical measures (Tinetti Balance Test, TB; Berg-Balance Test, BBT; Time up and go Test, TUG) and laboratory measures (centre of pressure parameters, CoP) in the eyes open (EO) and eyes closed (EC) conditions for post-stroke subjects. Significant correlation is indicated with an asterisk (p \< 0.05).

Discussion
==========

The main purpose of the study was to investigate the relation between the outcomes of instrumented posturography (the CoP parameters) and those of functional balance tests and scales in stroke subjects. Analysis of CoP components has proved to be useful in predicting the risk of falling and changes in postural performance \[[@B12]-[@B14],[@B23],[@B24],[@B30]-[@B33]\] in healthy and pathologic subjects, and can detect changes in balance control produced by different treatments \[[@B12]-[@B16],[@B31],[@B32]\].

In terms of the outcomes of the posturographic analysis, our results showed statistical difference for all the parameters between healthy and stroke subjects in the EO condition, whereas only four parameters were statistically different between the two subject populations in the EC condition (CoP path and CoPv, AP CoP path and AP CoPv). The lack of significant difference in the EC condition should not be necessarily attributed to a worst performance of SS subjects in EO condition, but could simply reflect the decrease in balance control in EC condition for CS subjects, decrease that has been well documented in previous studies \[[@B25]\]. While CS group's performance clearly worsens in EC condition, SS group shows poor balance in both EC and EO conditions. It is well known that visual information is an important component of balance even during quiet stance, as evidenced by the fact that both the amplitude and variability of body sway increase during EC condition \[[@B12]-[@B16]\]. The results of this study indicate that in SS subjects visual information did not improve balance performance as much as in healthy subjects. The control of upright posture is a complex mechanism that involves the continuous integration of afferent signals from the visual, vestibular and somatosensory systems \[[@B14],[@B15]\]; and it requires intact effectors in order to realize the correct postural program. Individuals who have experienced injury to the central nervous system in the form of a stroke may exhibit difficulty with sensory processing and/or motor planning. In these patients, the inability of peripheral sensory receptors to gain information about the environment may result in impaired postural control. Results might provide evidence that subjects affected by stroke rely on their vestibular and proprioceptive system in a greater degree than healthy subjects, who rely heavily on their visual feedback \[[@B26]\].

CoP path was significantly larger for the SS group in both AP and ML directions in EO and EC conditions, similarly to what reported by Corriveau et al. \[[@B31]\]. Consequently, the difference is clinically significant and confirms the postural instability in both directions (AP, ML) of the SS compared with the group of age-matched CS. In contrast, only the AP component of CoP was significantly different in the EC condition. Similar results were obtained for the CoP velocity, a parameter that is highly correlated to CoP path. In disagreement with Corriveau et al. \[[@B31]\] results on CoP path in SS suggests that patients affected by hemiplegia do not rely primarily on vision to compensate for motor control deficits in the lower extremity.

When analyzing the relation between posturographic analysis and clinical measures in SS subjects, the TUG scale showed the greater amount of correlation to CoP parameters (sway area, CoPv, CoPv in the AP direction for both the EO and EC condition; CoP path in the AP direction and EO condition; CoPv in the ML direction and EC condition). BBT was also correlated to CoP parameters, although to a lesser degree (CoP path in the AP direction and EO condition; CoPv and CoPv in the ML direction and EC condition; CoPv in the AP direction in both the EC and EO conditions). TB was never correlated to posturographic parameters. These results are in agreement with those of Corriveau et al. \[[@B31]\], who showed significant correlation between CoP-Center of mass amplitude and balance scales (BBS, Tinetti scale). Only one study \[[@B30]\] compared clinical evaluation with laboratory measures in a stroke population maintaining a quiet standing position in EO. BBS was compared with CoP speed, CoP root-mean-square (RMS) value, and CoP mean frequency in the AP and ML directions. In the AP direction, their results were comparable (R^2^ range, 0.50 to 0.57) to ours (R^2^ = 0.56). Surprisingly, significant correlations were not found in the ML direction.

An interesting result of our study is the correlation found between CoP path in the ML direction (R^2^ = 0.69) with the evaluation of the functional walking time measured by the TUG test. Also note that in a recent study, the TUG test proved to be a valid measure for predicting falls \[[@B12]\] as well as functional daily activity in elderly SS \[[@B12]\].

The correlation between functional evaluations and instrumental measures suggests that some of the CoP parameters provide an indication of postural instability in a quasi-static position that is also provided by functional tests used in a dynamic clinical evaluation. However, not all the CoP variables and the functional outcomes were correlated, and often only moderately. This results might indicate that the two techniques provide information about different aspects of balance. However, the precise balance characteristics described by functional balance evaluations are not easy to define, since a measure of deficit can never be perfectly related to a measure of incapacity because other factors enter into play to reduce performance. Certainly, the outcomes of instrumented posturography are useful to understand how a sensorimotor deficit results in functional limitations due to balance problems. In this respect, posturography is an essential tool in understanding the risk of falls \[[@B8],[@B23],[@B31]\].

Rehabilitations services are largely provided during the post-acute phase of a stroke and therapists and physiatrists document the clinical manifestations of stroke in order to select appropriate rehabilitation treatment \[[@B32]\]. The treatments are generally focused on optimizing SS motor performance by means of postural control exercises in order to diminish maladaptive strategies and promote increase loading of the affected lower limb, encourage reactive and anticipatory postural control strategies when displacement of center of mass increases \[[@B33]\]. With this in mind, the present results may indicate a specific role of CoP measurement in identifying those patients who will most likely benefit from rehabilitation and in identifying the more appropriate rehabilitation protocols.

Our results suggest that combining quantitative posturography and clinical evaluation whenever possible would enhance comprehension of postural impairments and disabilities in SS patients.

Conclusions
===========

This study provides the first attempt at finding a correlation between clinical and instrumental measures of balance in post-stroke subjects, understanding their individual and combined usefulness.

The observation that only some clinical and instrumental balance assessments are related might indicate that they measure different aspects of balance. Consistently with previous findings in healthy and pathologic subjects \[[@B12]-[@B16]\], results suggest that posturography parameters were found to provide insight into the postural control mechanisms of post-stroke subjects. Thus, this methodology should be recommended for use in clinical practice. As it has been previously demonstrated in other pathologies (e.g. Parkinson disease, see \[[@B16]\]) post-stroke subjects could also take advantage from the inclusion of quantitative posturography in their balance assessment. Our results may lead to a step forward towards the recommendation of the CoP parameters for use in clinical practice and in research.

Additional investigations are necessary to understand specificity and reliability of the individual center of pressure measures and to further clarify whether they are good candidate measures to discriminate among postural strategies used by post-stroke subjects.
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